Gene expression profiling reveals novel genes for improved risk classification and outcome prediction in pediatric acute lymphoblastic leukemia : identification, validation, and cloning of OPAL1.

Journal Article · 01 July 2004 · Proposed for publication in New England Journal of Medicine.

OSTI ID:964536

Chen, I-Ming ^[1]; Xu, Yuexian ^[1]; Ar, Kerem ^[1]; Murphy, Maurice H ^[1]; Veroff, Robert L ^[1]; Mosquera-Caro, Monica P ^[1]; Martin, Shawn Bryan; Shuster, Jonathan ^[2]; Wilson, Carla S ^[1]; Davidson, George S; Helman, Paul ^[1]; Andries, Erik ^[1]; Carroll, Andrew ^[2]; Harvey, Richard C ^[1]; Camitta, Bruce ^[2]; Bedrick, Ed ^[1]; Schultz, Frederick A ^[1]; Potter, Jeffrey W ^[1]; Wang, Xuefei ^[1]; Willman, Cheryl L ^[2] ; Atlas, Susan R ^[1]; Kang, Huining ^[1]

---

1. University of New Mexico, Albuquerque, NM
2. The Children's Oncology Group, Arcadia, CA

No abstract prepared.

• Research Organization: Sandia National Laboratories
• Sponsoring Organization: USDOE
• DOE Contract Number: AC04-94AL85000
• OSTI ID: 964536
• Report Number(s): SAND2004-3245J
• Journal Information: Proposed for publication in New England Journal of Medicine., Journal Name: Proposed for publication in New England Journal of Medicine.
• Country of Publication: United States
• Language: English

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
CLASSIFICATION
CLONING
FORECASTING
GENES
LEUKEMIA
PEDIATRICS
VALIDATION